Study objective: Opioid abuse and overdose constitute an ongoing health emergency. Many presume opioids have little potential for iatrogenic addiction when used as directed, particularly in short courses, as is typical of the emergency department (ED) setting. We preliminarily explore the possibility that initial exposure to opioids by EDs could be related to subsequent opioid misuse.
INTRODUCTION Background
During the past decade, a rapid increase in the sale of prescription opioids has been directly paralleled by an increase in overdose deaths. 1, 2 Approximately 16 million people in the United States report nonmedical use of prescription opioids. 3 In 2008, overdoses caused by prescription opioids surpassed those caused by heroin and cocaine combined, and drug overdose surpassed motor vehicle crashes as the number 1 cause of injury death for the first time. 4 Recent increases in heroin use may be due in part to individuals transitioning from nonmedical prescription opioid use to heroin. 5 The ways in which opioid prescribing leads to harm are not well characterized. To date, attention has focused on the problems of opioid abuse, diversion, and overdose. These issues pertain primarily to individuals who are already experiencing substance use disorders. 6 More recently, the possibility that legitimate use of prescription opioids has led to incident substance use disorders (iatrogenic addiction) is
Editor's Capsule Summary
What is already known on this topic Opioid abuse has increased during the past 15 years, and prescription opioids are one potential triggering source.
What question this study addressed
In a convenience sample of emergency department (ED) patients with declared opioid abuse, how often do they report prescriptive exposure as an initial event?
What this study adds to our knowledge Of the 59 respondents, 35 (59%) said medical prescriptive exposure preceded opioid abuse, with 10 reporting the ED as the source. However, 28 of the medically exposed patients (80%) had another existing abuse issue before opioid contact, and the timing of first opioid exposure and abuse varied widely.
How this is relevant to clinical practice ED prescribing can affect some individuals who will develop an opioid abuse syndrome, but the magnitude and course are uncertain.
beginning to gather attention. [6] [7] [8] [9] When iatrogenic addiction has been considered, it is almost exclusively in the context of chronic pain. 10 Not surprisingly, emergency providers commonly believe that short courses of opioid therapy for acute pain are safe and that their role in the current opioid crisis is limited to attenuating diversion. 11 However, several recent studies have demonstrated that short-course opioid therapy for acute pain is associated with recurrent use of opioids, raising the possibility that shortcourse opioid therapy may be a trigger for the onset of opioid-related substance use disorders. [7] [8] [9] If so, there are considerable health implications because more than 1 in every 6 patients discharged from an emergency department (ED) are given a prescription for an opioid pain reliever. 12 
Importance
The risk of iatrogenic addiction must be defined before providers can balance the risk of substance use disorders with the benefits of opioids for analgesia. Demonstrating that iatrogenic addiction is relevant to the ED setting could spur research needed to identify patients at risk of addiction and develop methods to modify that risk. Conversely, finding that the likelihood of iatrogenic addiction in ED patients is low could lead to improved pain treatment.
Goals of This Investigation
The goal of this study was to explore the extent to which ED patients who have come to use heroin or other opioids for nonmedical purposes report that a legitimate medical prescription (ie, prescription from their physician that is used for a medical purpose) was their first exposure to opioids, and how often that prescription came from an ED. Secondarily, we measured the proportion of patients using nonopioid substances before initial opioid exposure, the source of opioids between initial exposure and onset of regular nonmedical use, and the time from initial prescription to indicators of opioid use disorders.
MATERIALS AND METHODS Study Design
This was a structured, investigator-administered survey study that enrolled a convenience sample of ED patients who self-reported heroin or nonmedical prescription opioid use, defined as use of pharmaceutical opioids in a manner other than as prescribed. The study was approved by the institutional review board.
Setting
Subjects were recruited in an urban academic teaching hospital serving a predominantly adult population, with more than 70,000 encounters annually. It is the only adult Level I trauma center in the region, and it provides care for many of the region's uninsured.
Selection of Participants and Data Collection and Processing
Investigators screened for potential subjects with selfreported heroin or nonmedical prescription opioid use (defined as use to get high, using more than was prescribed, or receiving medication prescribed to someone else) from April 2015 through July 2015. This was primarily accomplished by reviewing the electronic medical record for chief complaints and triage notations including words such as heroin, withdrawal, overdose, and abscess. Potentially eligible patients could also be referred by ED staff. When no potential subjects were identified by these methods, study staff approached patients aged 18 to 40 years to assess for eligibility by asking about medication and drug use; general medication, opioid, and drug abuse questions were mixed to disguise the actual study focus. Subjects were excluded if they were unable or unwilling to consent, had previously enrolled in the study, or were in police custody. Although screening was not rigorously monitored, we did track which patients were approached and whether the approach was because of heroin use, opioid overdose, nonmedical prescription opioid use, or the general screen. Potential subjects were assured that their responses would not be directly linked to any identifiers, although identifiers were maintained in the screening log to prevent the possibility of duplicate enrollment. Structured, investigatoradministered surveys (Appendix E1, available online at http://www.annemergmed.com) were conducted discreetly in patient rooms, with curtains drawn or doors shut, during times when others were not in the immediate vicinity.
In addition to basic demographics, the survey asked subjects their age at first drug use; age at first regular drug use, defined as 1 or more times of use per week for at least 1 month; reasons for opioid use; opioid overdose history; use of addiction treatment services; and circumstances surrounding the initial opioid exposure. Subjects reporting a legitimate medical prescription as their initial opioid exposure were asked additional questions about the source of the initial prescription and sources of opioids used between the initial prescription and the onset of regular nonmedical use.
Methods of Measurement
Primary outcome measures were the proportion of subjects who reported their first exposure to opioids to have been a prescription given by the subjects' physician, which they used for a medical purpose ("medically exposed"), and of these, the proportion for whom the medication was provided by an ED.
Secondary outcome measures included the proportion with use, regular use (ie, at least once per week for at least 1 month), or treatment for substance use disorder involving nonopioid substances before initial opioid exposure; the source of opioids between initial exposure and onset of regular nonmedical use; and the duration from initial prescription to indicators of opioid use disorders, including nonmedical use, regular use to get high, and regular use to avoid withdrawal.
Primary Data Analysis
Analysis was descriptive. Proportions with 95% confidence intervals (CIs) were calculated for the primary outcomes. Statistical analyses were conducted with SPSS (version 22.0; IBM Corp, Armonk, NY). Figures were created with R (version 3.0.2, Vienna, Austria) and the package Beeswarm (version 0.1.6). 13, 14 Missing data were left missing and noted where applicable in the results.
RESULTS
Of 122 potential subjects approached, 79 were eligible, 60 consented, and 59 completed the survey. The 59 subjects qualified for inclusion because of heroin use (42/59; 71%), heroin overdose (12/59; 20%), and nonmedical prescription opioid use (5/59; 8%) ( Figure 1 ). Subjects had a median age of 32 years (IQR 26 to 39 years) and were primarily white (56/59; 95%), non-Hispanic (59/59; 100%), unemployed (34/59; 58%), male (33/59; 56%), and had completed high school (37/59; 63%) (Table) .
Fifty-nine percent of subjects reported that their initial exposure to opioids was a legitimate prescription from a medical provider, taken as directed (35/59; 59%; 95% CI 47% to 71%). Of these patients, 10 (10/35; 29%; 95% CI 16% to 45%) reported that their initial exposure came from an ED.
Most medically exposed subjects (28/35; 80%; 95% CI 65% to 91%) reported nonopioid substance use or treatment Figure 1 . Flow chart of enrollment and primary outcomes. *Approach was not tracked to differentiate between electronic medical record review and staff referral.
† Potential subjects identified through the electronic medical record review or staff referral were ineligible if they were in police custody, younger than 18 years, or lacked capacity for informed consent; general screen potential subjects were additionally ineligible if they did not report nonmedical opioid use. Approach was not complete for all potential subjects because of medical reasons or because the patient left the ED before reapproach.
for nonopioid substance use disorders preceding the initial opioid exposure. Emergency providers were reported to be a source of opioids between the initial exposure and regular nonmedical opioid use by 11 of 35 subjects (31%; 95% CI 18% to 48%) (Table) . Figure 2 shows the trajectory from initial exposure to indicators of opioid use disorders for 31 of 35 medically exposed subjects who reported the time of onset of nonmedical use. Figure 2A aggregates subjects by indicator of opioid use disorder, and Figure 2B depicts the trajectory for individual subjects. For most subjects, the onset of nonmedical use was nearly coincident or reasonably proximate to the initial exposure. Median time from exposure to onset of nonmedical use was 6 months for use to get high (N¼25; IQR 2 to 36), 12 months for regular use to get high (N¼24; IQR 2 to 36), 18 months for use to avoid withdrawal (N¼26; IQR 2 to 38), and 24 months for regular use to avoid withdrawal (N¼27; IQR 2 to 48). Eleven subjects (36%; 95% CI 21% to 53%) began nonmedical use within 2 months, and 9 of 11 (82%; 95% CI 53% to 96%) reported nonopioid substance use or treatment for alcohol abuse before initial opioid exposure.
LIMITATIONS
This study was intended as a highly preliminary exploration into the question of whether emergency providers might unknowingly contribute to iatrogenic addiction. Although provocative, our results are fundamentally limited and should be interpreted with caution. The study involved a small convenience sample that may not be representative of this ED or EDs in general. Opioid use between the initial exposure and the onset of opioid use disorder was not well defined; an initial exposure is necessary but not sufficient for addiction. Although our survey was structured, it was not validated in any way. Outcome measures depend on the accuracy of self-report, which is subject to recall bias at a minimum. Criteria for opioid use disorders were not assessed by -Not applicable to group without initial medical exposure. *Age is expressed as median (IQR) missing age for 1 medically exposed patient (n¼34). † Each subject could potentially report multiple factors (eg, reported using both marijuana and cocaine before initial opioid exposure). ‡ Regular use was defined as using substances at least once a week for 1 month or more.
standardized clinical assessment. According to our experiences, subjects were able to report the sequence of events after initial opioid exposure but had difficulty with precise timing of events. Social desirability bias may have contributed to inaccurate reports, although anonymity of the survey was emphasized. Finally, although our data suggest the possibility of a link, at least temporally, between ED exposures and opioid substance use disorders, they cannot be used to estimate risk (ie, what proportion of patients prescribed opioids in the ED will develop an addiction) or determine the degree of causality.
DISCUSSION
To date, the role of emergency medicine in the current opioid epidemic has focused almost exclusively on reducing Figure 2 . A, Time from initial medical exposure to types of nonmedical use, organized by indicator of substance use disorder. Each dot represents a single case and each line represents the median time to each indicator. All 31 subjects reported nonmedical opioid use to get high or avoid withdrawal, but not all subjects reported both. B, Time from initial medical exposure to the onset of nonmedical use and regular nonmedical use, organized by individual subject. *Regular use was defined as using at least once a week for 1 month or more.
the supply of opioids available for misuse and diversion. Although important, this only pertains to patients already experiencing opioid use disorders and does not address how those individuals first came to be involved in opioid abuse. 6, 15, 16 Our study, although highly preliminary, is important as the first direct exploration of whether opioids prescribed by emergency physicians may contribute to the problem of iatrogenic addiction. We found that among ED patients with opioid-use disorders, half were first exposed to opioids by a prescription from a medical provider, often an emergency provider, which they took as directed. That initial exposure was most frequently followed by nonmedical use, use to get high, or use to avoid withdrawal within 6 to 12 months. This close temporal association raises the possibility that EDs are part of an iatrogenic contribution to incident addiction. Even the possibility that ED prescriptions can contribute to iatrogenic addiction requires urgent study, given the magnitude of the current health crisis and the frequency with which emergency providers prescribe opioids. 12 These findings complement studies of opioid use in the year after treatment for acute pain. Clarke et al 9 found that 3.1% of opioid-naive patients undergoing major elective surgery were still receiving opioids after 90 days. Alam et al 8 found that although the overall rate of recurrent opioid use at 1 year was only 8% for patients undergoing minor surgery, opioid-naive patients who received an opioid prescription were 44% more likely to fill additional prescriptions at 1 year than opioid-naive patients who did not receive a prescription. Hoppe et al 7 found that 12% of opioid-naive patients discharged from an ED with an acute pain condition had recurrent opioid use at 1 year. Opioidnaive patients who were discharged with and filled an opioid prescription were nearly twice as likely to have recurrent opioid use at 1 year compared with opioid-naive patients who did not receive an opioid prescription. 7 These retrospective studies provide important preliminary insights into the possible magnitude of risk for opioidnaive patients but do not clarify whether subsequent use was linked to the initial prescription or whether it was appropriate.
Our results suggest that initial opioid exposures from medical sources may be contributory to opioid use disorders. Opioid abuse and addiction do not manifest without exposure, and in many cases onset of regular nonmedical use was proximate to an initial medical exposure, often occurring within 2 months. This is alarming and may indicate that the initial exposure is uniquely contributory to opioid use disorders in some cases. Such patients are likely "primed" to be unusually susceptible to the addictive potential of opioids. More than 80% of patients with an early transition to nonmedical use reported nonopioid substance use at their initial opioid exposure. Alternatively, individuals with an early transition to nonmedical use may have received an unusually highintensity exposure (ie, dose, agent, or duration) in the weeks after initial exposure.
Our study does not characterize the extent to which an initial medical exposure contributes to eventual opioid use disorders. Future research in this area will need to attend to questions of which exposures are contributory to opioid use disorders and the importance of initial exposures relative to subsequent exposures. Such work will be critical to developing interventions that can prevent or attenuate the development of opioid use disorders among patients who are at risk and medically exposed. The role of emergency medicine in iatrogenic addiction may not be limited to initial exposures. We found that 31% of subjects reported that the ED was a source of opioids in the time between their initial exposure and the onset of regular opioid use to get high or avoid withdrawal.
The issue of iatrogenic addiction calls into question the appropriate balance between adequate pain treatment and the potential risk of developing opioid use disorders. 6 This risk will vary by individual, as does severity of pain. Further research into factors that may predict susceptibility to addiction could lead to the development of screening tools appropriate for the acute care environment that could help providers predict which patients are most at risk for opioid addiction. This could in turn inform risk-benefit analysis when treating pain.
In summary, more than half of patients with opioid use disorders self-reported that their initial opioid exposure was a prescription from their physician, which they took as prescribed, and of these, 29% were ED prescriptions. Many of these patients began a pattern of regular opioid use shortly thereafter. Although short courses of opioid medication are insufficient to cause dependence or addiction, exposure from EDs may be a contributory step in the process. This topic requires urgent investigation so that emergency providers can adequately balance the need for pain treatment with the risks of subsequent addiction. Author contributions: All authors contributed to the conception, design, and interpretation of the study. RMA and KWH managed the data and performed statistical analysis. MMB and RMA drafted the article, and all authors contributed substantially to its revision. MSL takes responsibility for the paper as a whole. 
